About 1 result found for searched term "RLY-2608" (0.081 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M45258 | RLY-2608 | PI3K |
| Zovegalisib | ||
| RLY-2608 is a first-in-class, orally active, selective inhibitor of PI3Ka metabolism. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
